185 related articles for article (PubMed ID: 24081742)
1. The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women.
Su HI; Maas K; Sluss PM; Chang RJ; Hall JE; Joffe H
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1961-6. PubMed ID: 24081742
[TBL] [Abstract][Full Text] [Related]
2. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
[TBL] [Abstract][Full Text] [Related]
3. Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats.
Tungmahasuk D; Fungbun N; Laoharatchatathanin T; Terashima R; Kurusu S; Kawaminami M
J Reprod Dev; 2018 Apr; 64(2):129-134. PubMed ID: 29249775
[TBL] [Abstract][Full Text] [Related]
4. [Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].
Gris-Martínez JM; Trillo-Urrutia L; Gómez-Cabeza JJ; Encabo-Duró G
Med Clin (Barc); 2016 Feb; 146(3):97-103. PubMed ID: 26194532
[TBL] [Abstract][Full Text] [Related]
5. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
Kummer NE; Feinn RS; Griffin DW; Nulsen JC; Benadiva CA; Engmann LL
Hum Reprod; 2013 Jan; 28(1):152-9. PubMed ID: 23077235
[TBL] [Abstract][Full Text] [Related]
6. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?
Hasky N; Uri-Belapolsky S; Goldberg K; Miller I; Grossman H; Stemmer SM; Ben-Aharon I; Shalgi R
Hum Reprod; 2015 May; 30(5):1089-101. PubMed ID: 25796551
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist.
Hagen CP; Sørensen K; Anderson RA; Juul A
Fertil Steril; 2012 Nov; 98(5):1326-30. PubMed ID: 22901847
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients.
Marder W; McCune WJ; Wang L; Wing JJ; Fisseha S; McConnell DS; Christman GM; Somers EC
Gynecol Endocrinol; 2012 Aug; 28(8):624-7. PubMed ID: 22296584
[TBL] [Abstract][Full Text] [Related]
9. Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty.
Tao Y; Si C; Li H; Han J; Hou H; Yang M
Ann Palliat Med; 2020 Jan; 9(1):53-62. PubMed ID: 32005063
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin releasing hormone antagonists suppress aromatase and anti-Müllerian hormone expression in human granulosa cells.
Winkler N; Bukulmez O; Hardy DB; Carr BR
Fertil Steril; 2010 Oct; 94(5):1832-9. PubMed ID: 19896656
[TBL] [Abstract][Full Text] [Related]
11. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.
Badawy A; Elnashar A; El-Ashry M; Shahat M
Fertil Steril; 2009 Mar; 91(3):694-7. PubMed ID: 18675959
[TBL] [Abstract][Full Text] [Related]
14. Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal.
Cooper BC; Sites CK; Casson PR; Toth MJ
Fertil Steril; 2007 May; 87(5):1131-8. PubMed ID: 17478172
[TBL] [Abstract][Full Text] [Related]
15. Midcycle administration of single-dose GnRHa for luteal phase failure in women with ovarian hyperstimulation. A report of five cases.
Wu TC
J Reprod Med; 2000 Feb; 45(2):156-8. PubMed ID: 10710751
[TBL] [Abstract][Full Text] [Related]
16. Pituitary response to early follicular-phase minidose gonadotropin releasing hormone agonist (GnRHa) therapy: evidence for a second flare.
Deaton JL; Bauguess P; Huffman CS; Miller KA
J Assist Reprod Genet; 1996 May; 13(5):390-4. PubMed ID: 8739054
[TBL] [Abstract][Full Text] [Related]
17. Regulation of AMH and SCF expression in human granulosa cells by GnRH agonist and antagonist.
Dong M; Huang L; Wang W; Du M; He Z; Mo Y; Yang D
Pharmazie; 2011 Jun; 66(6):436-9. PubMed ID: 21699083
[TBL] [Abstract][Full Text] [Related]
18. The impact of GnRH agonists in patients with endometriosis on prolactin and sex hormone levels: a pilot study.
Marschalek J; Ott J; Husslein H; Kuessel L; Elhenicky M; Mayerhofer K; Franz MB
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():156-159. PubMed ID: 26546756
[TBL] [Abstract][Full Text] [Related]
19. Dose-finding study of Leuplin depot for prevention of premature luteinizing hormone surge during controlled ovarian stimulation: a pilot study in intrauterine insemination treatment.
Chen HJ; Lin YH; Huang MZ; Seow KM; Huang LW; Hsieh BC; Tzeng CR; Hwang JL
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):235-8. PubMed ID: 27125407
[TBL] [Abstract][Full Text] [Related]
20. Cessation of low-dose gonadotropin releasing hormone agonist therapy followed by high-dose gonadotropin stimulation yields a favorable ovarian response in poor responders.
Wang PT; Lee RK; Su JT; Hou JW; Lin MH; Hu YM
J Assist Reprod Genet; 2002 Jan; 19(1):1-6. PubMed ID: 11893009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
